TGF-β3 inhibits antibody production by human B cells

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Tsuchida, Yumi ^a   Sumitomo, Shuji ^a   Ishigaki, Kazuyoshi ^a,b   Suzuki, Akari ^b   Kochi, Yuta ^b   Tsuchiya, Haruka ^a   Ota, Mineto ^a   Komai, Toshihiko ^a   Inoue, Mariko ^a   Morita, Kaoru ^a   Okamura, Tomohisa ^a,c   Yamamoto, Kazuhiko ^a   Fujio, Keishi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B LYMPHOCYTE RECEPTOR; INTERFERON REGULATORY FACTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; X BOX BINDING PROTEIN 1; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MESSENGER RNA; PROTEIN KINASE SYK; SMAD PROTEIN; TRANSCRIPTION FACTOR;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PLASMABLAST; CELL DIFFERENTIATION; DRUG EFFECTS; GENETICS; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ANTIBODY FORMATION; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTIDINE DEAMINASE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PHOSPHORYLATION; RNA, MESSENGER; SMAD PROTEINS; SYK KINASE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

EID: 85008386286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169646     Document Type: Article

References (53)

1. Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-beta - an excellent servant but a bad master. J Transl Med. 2012; 10: 183. doi: 10.1186/1479-5876-10-183 PMID: 22943793
2. Pelton RW, Dickinson ME, Moses HL, Hogan BL. In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development. 1990; 110: 609-20. PMID: 1723948
3. Dunker N, Krieglstein K. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem. 2000; 267: 6982-8. PMID: 11106407
4. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992; 359: 693-9. doi: 10.1038/359693a0 PMID: 1436033
5. Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, et al. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol. 1995; 155: 3205-12. PMID: 7673733
6. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995; 108 (Pt 3): 985-1002.
7. Ask K, Bonniaud P, Maass K, Eickelberg O, Margetts PJ, Warburton D, et al. Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but notTGF-beta3. Int J Biochem Cell Biol. 2008; 40: 484-95. doi: 10.1016/j.biocel.2007.08.016 PMID: 17931953
8. Finnson KW, McLean S, Di Guglielmo GM, Philip A. Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring. Adv Wound Care (New Rochelle). 2013; 2: 195-214.
9. Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol. 2012; 13: 925-31. doi: 10.1038/ni.2406 PMID: 22990890
10. Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS. Further studies of the role of transforming growth factor-beta in human Bcell function. J Immunol. 1989; 143: 1868-74. PMID: 2550546
11. Kehrl JH, Thevenin C, Rieckmann P, Fauci AS. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol. 1991; 146: 4016-23. PMID: 1903417
12. Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, Araki S, et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med. 1989; 170: 1415-20. PMID: 2677210
13. Bouchard C, Fridman WH, Sautes C. Effect of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes. J Immunol. 1997; 159: 4155-64. PMID: 9379008
14. Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med. 1989; 170: 1039-44. PMID: 2788703
15. Dullaers M, Li D, Xue Y, Ni L, Gayet I, Morita R, et al. AT cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity. 2009; 30: 120-9. doi: 10.1016/j.immuni.2008.11.008 PMID: 19144318
16. van Vlasselaer P, Punnonen J, de Vries JE Transforming growth factor-beta directs IgA switching in human B cells. J Immunol. 1992; 148: 2062-7. PMID: 1347548
17. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001; 194: 629-44. PMID: 11535631
18. Bakkebo M, Huse K, Hilden VI, Smeland EB, Oksvold MP. TGF-beta-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK. BMC Immunol. 2010; 11: 57. doi: 10.1186/1471-2172-11-57 PMID: 21092277
19. Spender LC, Carter MJ, O'Brien DI, Clark LJ, Yu J, Michalak EM, et al. Transforming growth factor-beta directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomas. J Biol Chem. 2013; 288: 5198-209. doi: 10.1074/jbc.M112.410274 PMID: 23243310
20. Chen G, Ghosh P, O'Farrell T, Munk R, Rezanka LJ, Sasaki CY, et al. Transforming growth factor beta1 (TGF-beta1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53. J Biol Chem. 2012; 287: 23184-95. doi: 10.1074/jbc.M112.351411 PMID: 22621932
21. Chen G, Ghosh P, Osawa H, Sasaki CY, Rezanka L, Yang J, et al. Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines. Blood. 2007; 109: 5301-7. doi: 10.1182/blood-2006-06-032128 PMID: 17339425
22. Bakhshayesh M, Zaker F, Hashemi M, Katebi M, Solaimani M. TGF- beta1-mediated apoptosis associated with SMAD-dependent mitochondrial Bcl-2 expression. Clin Lymphoma Myeloma Leuk. 2012; 12: 138-43. doi: 10.1016/j.clml.2011.12.001 PMID: 22297256
23. Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13: 991-9. doi: 10.1038/ni.2416 PMID: 22961052
24. Shah S, Qiao L. Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF-beta3. Eur J Immunol. 2008; 38: 2488-98. doi: 10.1002/eji.200838201 PMID: 18792402
25. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-beta3-expressing CD4 +CD25-LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015; 6: 6329. doi: 10.1038/ncomms7329 PMID: 25695838
26. Okamura T, Fujio K, Shibuya M, Sumitomo S, Shoda H, Sakaguchi S, et al. CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci USA. 2009; 106: 13974-9. doi: 10.1073/pnas.0906872106 PMID: 19666526
27. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011; 17: 10-2.
28. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNAseq aligner. Bioinformatics. 2013; 29: 15-21. doi: 10.1093/bioinformatics/bts635 PMID: 23104886
29. Anders S, Pyl PT, Huber W. HTSeq - a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015; 31: 166-9. doi: 10.1093/bioinformatics/btu638 PMID: 25260700
30. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26: 139-40. doi: 10.1093/bioinformatics/btp616 PMID: 19910308
31. Kramer A, Green J, Pollard J Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014; 30: 523-30. doi: 10.1093/bioinformatics/btt703 PMID: 24336805
32. Cerutti A, Zan H, Schaffer A, Bergsagel L, Harindranath N, Max EE, et al. CD40 ligand and appropriate cytokines induce switching to Ig G, Ig A, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol. 1998; 160: 2145-57. PMID: 9498752
33. Oida T, Weiner HL. Depletion of TGF-beta from fetal bovine serum. J Immunol Methods. 2010; 362: 195-8. doi: 10.1016/j.jim.2010.09.008 PMID: 20837018
34. Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D, et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet. 2004; 36: 453-61. doi: 10.1038/ng1343 PMID: 15098032
35. Green JA, Cyster JG. S1PR2 links germinal center confinement and growth regulation. Immunol Rev. 2012; 247: 36-51. doi: 10.1111/j.1600-065X.2012.01114.x PMID: 22500830
36. Schmid CA, Robinson MD, Scheifinger NA, Muller S, Cogliatti S, Tzankov A, et al. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. J Exp Med. 2015; 212: 775-92. doi: 10.1084/jem.20141957 PMID: 25847947
37. Sohn HW, Krueger PD, Davis RS, Pierce SK. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood. 2011; 118: 6332-41. doi: 10.1182/blood-2011-05-353102 PMID: 21908428
38. Lawrie CH, Shilling R, Troussard X, Cattan H, Mossafa H, Pezzella F, et al. Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFbeta signalling pathways. Leukemia. 2009; 23: 581-3. doi: 10.1038/leu.2008.223 PMID: 18754033
39. Capra M, Nuciforo PG, Confalonieri S, Quarto M, Bianchi M, Nebuloni M, et al. Frequent alterations in the expression of serine/threonine kinases in human cancers. Cancer Res. 2006; 66: 8147-54. doi: 10.1158/0008-5472.CAN-05-3489 PMID: 16912193
40. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M, et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol. 2010; 6: 377. doi: 10.1038/msb.2010.31 PMID: 20531406
41. Grumont RJ, Gerondakis S. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med. 2000; 191: 1281-92. PMID: 10770796
42. Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015; 15: 160-71. doi: 10.1038/nri3795 PMID: 25698678
43. Jelicic K, Cimbro R, Nawaz F, Huang da W, Zheng X, Yang J, et al. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-beta1 production and FcRL4 expression. Nat Immunol. 2013; 14: 1256-65. doi: 10.1038/ni.2746 PMID: 24162774
44. Chikuma S, Suita N, Okazaki IM, Shibayama S, Honjo T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol. 2012; 13: 596-603. doi: 10.1038/ni.2293 PMID: 22544392
45. Klein J, Ju W, Heyer J, Wittek B, Haneke T, Knaus P, et al. B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-beta-directed IgA switching and changes in B cell fate. J Immunol. 2006; 176: 2389-96. PMID: 16455997
46. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. Embo j. 1999; 18: 1280-91. doi: 10.1093/emboj/18.5.1280 PMID: 10064594
47. Kee BL, Rivera RR, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol. 2001; 2: 242-7. doi: 10.1038/85303 PMID: 11224524
48. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ. Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol. 2003; 211: 105-13. PMID: 14656483
49. Caron G, Hussein M, Kulis M, Delaloy C, Chatonnet F, Pignarre A, et al. Cell-Cycle-Dependent Reconfiguration of the DNA Methylome during Terminal Differentiation of Human B Cells into Plasma Cells. Cell Rep. 2015; 13: 1059-71. doi: 10.1016/j.celrep.2015.09.051 PMID: 26565917
50. Tangye SG, Avery DT, Hodgkin PD. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol. 2003; 170: 261-9. PMID: 12496408
51. Gugasyan R, Grumont R, Grossmann M, Nakamura Y, Pohl T, Nesic D, et al. Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol Rev. 2000; 176: 134-40. PMID: 11043773
52. Fleischer SJ, Giesecke C, Mei HE, Lipsky PE, Daridon C, Dorner T. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Arthritis Rheumatol. 2014; 66: 3424-35. doi: 10.1002/art.38854 PMID: 25156507
53. Hall BE, Wankhade UD, Konkel JE, Cherukuri K, Nagineni CN, Flanders KC, et al. Transforming growth factor-beta3 (TGF-beta3) knock-in ameliorates inflammation due to TGF-beta1 deficiency while promoting glucose tolerance. J Biol Chem. 2013; 288: 32074-92. doi: 10.1074/jbc.M113.480764 PMID: 24056369